Galmed Pharmaceuticals Ltd.
GLMD
$1.56
$0.000.28%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -122.97% | 13.41% | -59.18% | 29.76% | 29.76% |
Total Depreciation and Amortization | -- | -- | -100.00% | 722.22% | 722.22% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 399.17% | -49.35% | 1,435.29% | 700.00% | 700.00% |
Change in Net Operating Assets | 782.61% | 80.36% | -159.11% | -145.54% | -145.54% |
Cash from Operations | -24.68% | 36.23% | -119.27% | 25.60% | 25.60% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -428.23% | -153.47% | -255.73% | 97.45% | 97.45% |
Cash from Investing | -428.23% | -153.47% | -255.73% | 97.45% | 97.45% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -- | -- | -- | -- | -- |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -47.20% | 108.30% | -467.13% | 156.65% | 156.65% |